TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33998580

Group type: EXPERIMENTAL
Intervention: Medical undergraduate students
Number of subjects: 216

Group type: COMPARATOR
Intervention: Dental undergraduate students
Number of subjects: 216
Study: 34059304

Group type: EXPERIMENTAL
Intervention: Ceramic-ceramic FDPs
Number of subjects: 96

Group type: COMPARATOR
Intervention: Metal-ceramic FDPs
Number of subjects: 96
Study: 36047294

Group type: EXPERIMENTAL
Intervention: J-Calc-CTO score
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Dense calcification (calcified-index >12)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Calcification in the center of the lumen
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Procedural success rate
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: 30-min wire crossing
Number of subjects: 137
Study: 32232954

Group type: EXPERIMENTAL
Intervention: Family focused therapy for individuals at CHR (6 months)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Family psychoeducational treatment (6 months)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Matched controls (no specific treatment mentioned)
Number of subjects: 0
Study: 32295554

Group type: EXPERIMENTAL
Intervention: Sitting position
Number of subjects: 1020

Group type: COMPARATOR
Intervention: Lying position
Number of subjects: 1020

Group type: EXPERIMENTAL
Intervention: Early stylet removal
Number of subjects: 1020

Group type: COMPARATOR
Intervention: Late stylet removal
Number of subjects: 1020
Study: 35015247

Group type: EXPERIMENTAL
Intervention: Asynchronous binocular treatment using 3D movies with amblyopic eye stimulated first for 10.5 hours over <3 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Asynchronous binocular treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Patching alone
Number of subjects: 0
Study: 33605356

Group type: EXPERIMENTAL
Intervention: Audiovisual eyeglasses (AVE)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Conventional behavior management techniques (control)
Number of subjects: 44
Study: 35900031

Group type: EXPERIMENTAL
Intervention: Test nilotinib capsule (200 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Reference nilotinib capsule (200 mg)
Number of subjects: 30
Study: 33369651

Group type: EXPERIMENTAL
Intervention: Disability Rating Scale (DRS) measured during weeks 1 to 4 after TBI
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Disability Rating Scale (DRS)
Number of subjects: 200
Study: 35413533

Group type: EXPERIMENTAL
Intervention: Monitoring with an emphasis on acceptance training (MAT)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Monitoring training (MT)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Emotional regulation course (Control)
Number of subjects: 149
Study: 34821563

Group type: EXPERIMENTAL
Intervention: Therapist-guided ICBT
Number of subjects: 1169

Group type: EXPERIMENTAL
Intervention: Self-help ICBT
Number of subjects: 1169

Group type: COMPARATOR
Intervention: Information-only control
Number of subjects: 1169
Study: 36495356

Group type: EXPERIMENTAL
Intervention: Active prayer (n=94)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Passive prayer (n=62)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Poem reading (control group, n=52)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 208
Study: 32839833

Group type: EXPERIMENTAL
Intervention: Erythritol air polishing
Number of subjects: 30

Group type: COMPARATOR
Intervention: Scaling and root planing with hand curettes and ultrasonic instruments
Number of subjects: 30
Study: 32427792

Group type: EXPERIMENTAL
Intervention: Silicone sheets
Number of subjects: 0

Group type: COMPARATOR
Intervention: Paper tape
Number of subjects: 0
Study: 36454806

Group type: EXPERIMENTAL
Intervention: Training package for Risk Management (RM)
Number of subjects: 61
Study: 35685819

Group type: EXPERIMENTAL
Intervention: 50000 IU vitamin D3 per week
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 33000503

Group type: EXPERIMENTAL
Intervention: Tralokinumab 300 mg every 2 weeks (Q2W) plus topical corticosteroids (TCS) as needed
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo plus topical corticosteroids (TCS) as needed
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tralokinumab Q2W plus TCS as needed
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tralokinumab Q4W plus TCS as needed
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patients who did not achieve IGA 0/1 and EASI 75 with tralokinumab Q2W at week 16
Number of subjects: 0
Study: 32398441

Group type: EXPERIMENTAL
Intervention: Lidocaine with 1.0 ppm DEX (1.8 μg)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Lidocaine with 2.0 ppm DEX (3.6 μg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Lidocaine with 1:80,000 adrenaline (22.5 μg)
Number of subjects: 19
Study: 35964135

Group type: EXPERIMENTAL
Intervention: Low-frequency rTMS at the contralesional primary motor cortex (M1) along with routine medical care
Number of subjects: 140

Group type: COMPARATOR
Intervention: Sham rTMS along with routine medical care
Number of subjects: 140
Study: 33280266

Group type: EXPERIMENTAL
Intervention: Laparoscopic resection
Number of subjects: 449

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 449

Group type: EXPERIMENTAL
Intervention: Full-time employment presurgery
Number of subjects: 449

Group type: EXPERIMENTAL
Intervention: Distant metastases at baseline
Number of subjects: 449

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 449
Study: 34087418

Group type: EXPERIMENTAL
Intervention: Glycopyrrolate bolus (0.4 mg IV)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Titrated glycopyrrolate (0.01 mg IV every 3 min as needed)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (no glycopyrrolate)
Number of subjects: 8
Study: 32645143

Group type: EXPERIMENTAL
Intervention: Olfactory memory training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Visual memory training
Number of subjects: 0
Study: 35869477

Group type: EXPERIMENTAL
Intervention: Online collaborative learning (OCL)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Face-to-face environment
Number of subjects: 124
Study: 33971735

Group type: EXPERIMENTAL
Intervention: Meniscectomy or Exercise (specific intervention details not provided)
Number of subjects: 140
Study: 34762233

Group type: EXPERIMENTAL
Intervention: TEAS at 20 mA
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: TEAS at 30 mA
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: TEAS at 40 mA
Number of subjects: 200
Study: 33087164

Group type: EXPERIMENTAL
Intervention: Telephone recall with mailed self-sample HPV testing kit (n = 756)
Number of subjects: 2268

Group type: EXPERIMENTAL
Intervention: Telephone recall with mailed self-sample HPV testing kit and patient navigation (n = 756)
Number of subjects: 2268

Group type: COMPARATOR
Intervention: Telephone recall (enhanced usual care, n = 756)
Number of subjects: 2268
Study: 32691455

Group type: EXPERIMENTAL
Intervention: iCAN‐DO (cocreated internet‐based stepped care)
Number of subjects: 245

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 245
Study: 35925736

Group type: EXPERIMENTAL
Intervention: Informant-reported cognitive decline
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Self-reported cognitive decline
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Underestimators (68 participants)
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Congruent estimators (94 participants)
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Overestimators (144 participants)
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Cognitive performance
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Discrepancy between self- and informant-report
Number of subjects: 306
Study: 33675596

Group type: EXPERIMENTAL
Intervention: Telephone intervention by a specific nurse 2 days before colonoscopy
Number of subjects: 162

Group type: COMPARATOR
Intervention: Control group received education only on the day of appointment
Number of subjects: 162
Study: 32660604

Group type: EXPERIMENTAL
Intervention: Serious Games using Leap Motion Controller (LMC) plus conventional rehabilitation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional rehabilitation
Number of subjects: 0
Study: 34558386

Group type: EXPERIMENTAL
Intervention: 20-minute sanitary pad test
Number of subjects: 50

Group type: COMPARATOR
Intervention: 60-minute sanitary pad test
Number of subjects: 50
Study: 32530426

Group type: EXPERIMENTAL
Intervention: Pay-it-forward arm
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Pay-what-you-want arm
Number of subjects: 301

Group type: COMPARATOR
Intervention: Standard-of-care arm
Number of subjects: 301
Study: 34406656

Group type: EXPERIMENTAL
Intervention: Add-on cannabidiol (CBD) titrated from 2.5 to 20 mg/kg/day, with potential increase to 30 mg/kg/day based on response and tolerance.
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Add-on cannabidiol (CBD) treatment
Number of subjects: 315
Study: 33189630

Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan
Number of subjects: 678

Group type: COMPARATOR
Intervention: Enalapril (control from EVALUATE‐HF study)
Number of subjects: 678
Study: 36333195

Group type: EXPERIMENTAL
Intervention: Web-based, theory-guided narrative intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional genetic counseling
Number of subjects: 0
Study: 32950038

Group type: EXPERIMENTAL
Intervention: Enhanced post-donation instruction sheet (PDIS)
Number of subjects: 12935

Group type: COMPARATOR
Intervention: Standard post-donation instruction sheet (PDIS)
Number of subjects: 12935
Study: 32371518

Group type: EXPERIMENTAL
Intervention: Structured Individualised Intervention and Recovery (SITAR) with an individually tailored recovery plan
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard care (without individually tailored recovery plan)
Number of subjects: 200
Study: 35891122

Group type: EXPERIMENTAL
Intervention: TENS on first visit only (TN)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: TENS on second visit only (NT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (NN)
Number of subjects: 30
Study: 34794220

Group type: EXPERIMENTAL
Intervention: Irinotecan plus S‐1 (intravenous infusion of irinotecan 160 mg/m(2) on day 1 and oral S‐1 80‐120 mg on days 1‐10, repeated every 14 days)
Number of subjects: 46
Study: 32183057

Group type: EXPERIMENTAL
Intervention: Total protein intake of 1 g·Kg−1·d−1 in week 2
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: Nutritional intake
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: Changes in z-scores to 4 weeks and 36 weeks’ CA
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: Macronutrient intakes from birth to 4 weeks
Number of subjects: 434
Study: 35144602

Group type: EXPERIMENTAL
Intervention: On-site testing using the Xpert® CT/NG test
Number of subjects: 847

Group type: COMPARATOR
Intervention: Off-site testing
Number of subjects: 847

Group type: EXPERIMENTAL
Intervention: On-site testing
Number of subjects: 847
Study: 34491999

Group type: EXPERIMENTAL
Intervention: Healthier supermarket layout intervention (new fresh fruit and vegetable sections near entrances, frozen vegetables repositioned to entrance aisle, removal of confectionery from checkouts)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Healthier supermarket layout intervention
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 150
Study: 34090551

Group type: EXPERIMENTAL
Intervention: Cervical manual traction
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Trunk stabilization maneuver
Number of subjects: 54
Study: 36235676

Group type: EXPERIMENTAL
Intervention: Maximal graded exercise stress test (GEST)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Non-exercise CONTROL
Number of subjects: 15
Study: 34001723

Group type: EXPERIMENTAL
Intervention: Aprocitentan (dual endothelin-receptor antagonist)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Moderately dosed angiotensin-converting enzyme inhibitor
Number of subjects: 0
Study: 33295528

Group type: EXPERIMENTAL
Intervention: Communication by card
Number of subjects: 189

Group type: COMPARATOR
Intervention: Verbal communication
Number of subjects: 189
Study: 35311705

Group type: EXPERIMENTAL
Intervention: MCI (prodromal AD)
Number of subjects: 54

Group type: COMPARATOR
Intervention: SCD
Number of subjects: 54

Group type: COMPARATOR
Intervention: AD dementia
Number of subjects: 54
Study: 33506030

Group type: EXPERIMENTAL
Intervention: Food safety knowledge training
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: Food safety knowledge
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: Food safety practices
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: Food safety training
Number of subjects: 430
Study: 35909029

Group type: EXPERIMENTAL
Intervention: Scenario‐Tailored Opioid Messaging Program intervention
Number of subjects: 648

Group type: COMPARATOR
Intervention: Routine information (control)
Number of subjects: 648
Study: 32171768

Group type: EXPERIMENTAL
Intervention: Quarterly azithromycin distribution
Number of subjects: 60

Group type: COMPARATOR
Intervention: Annual azithromycin distribution
Number of subjects: 60

Group type: COMPARATOR
Intervention: Biennial azithromycin distribution
Number of subjects: 60

Group type: COMPARATOR
Intervention: Biannual azithromycin distribution
Number of subjects: 60

Group type: COMPARATOR
Intervention: Delayed azithromycin distribution
Number of subjects: 60
Study: 34750747

Group type: EXPERIMENTAL
Intervention: PPV-guided fluid therapy
Number of subjects: 77

Group type: COMPARATOR
Intervention: CVP-guided fluid therapy
Number of subjects: 77
Study: 34019245

Group type: EXPERIMENTAL
Intervention: Atezolizumab plus platinum-based chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo plus platinum-based chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atezolizumab plus platinum-based chemotherapy with PD-L1 expression of at least 5%
Number of subjects: 0
Study: 35007480

Group type: EXPERIMENTAL
Intervention: Hypnosis
Number of subjects: 30

Group type: COMPARATOR
Intervention: Nicotine-replacement therapies (NRT)
Number of subjects: 30
Study: 33572448

Group type: EXPERIMENTAL
Intervention: EMOVERE program (seven two-hour sessions over a month)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group (received no intervention)
Number of subjects: 88
Study: 32534843

Group type: EXPERIMENTAL
Intervention: Gabapentin 600 mg preoperatively
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study: 34701521

Group type: EXPERIMENTAL
Intervention: Prophylactic cranial irradiation (PCI) at 25 Gy in 10 fractions using 3D conformal radiotherapy (3D-CRT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: MRI surveillance alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hippocampal-avoidance PCI (HA-PCI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HA-IMRT with memantine for salvage treatment in MRI surveillance group
Number of subjects: 0
Study: 34357539

Group type: EXPERIMENTAL
Intervention: Bot/VPN Check
Number of subjects: 1100

Group type: EXPERIMENTAL
Intervention: Truthfulness/Attention Check
Number of subjects: 1100

Group type: EXPERIMENTAL
Intervention: Stringent Arm - All Checks
Number of subjects: 1100

Group type: COMPARATOR
Intervention: Control Arm
Number of subjects: 1100
Study: 34189633

Group type: EXPERIMENTAL
Intervention: Ankle exoskeleton providing adaptive plantar-flexor assistance
Number of subjects: 7

Group type: COMPARATOR
Intervention: Normal walking condition (without exoskeleton)
Number of subjects: 7
Study: 32348168

Group type: EXPERIMENTAL
Intervention: Conventional anaesthesia (CA)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Vibrational anaesthesia (VBA)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Computer-controlled local anaesthesia delivery (CCLAD)
Number of subjects: 105
Study: 36472933

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI)
Number of subjects: 3760

Group type: COMPARATOR
Intervention: Diabetes support and education (Control)
Number of subjects: 3760
Study: 33663100

Group type: EXPERIMENTAL
Intervention: Edaravone treatment on top of conventional treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 60
Study: 34918875

Group type: EXPERIMENTAL
Intervention: Metopimazine (MPZ) 60 mg
Number of subjects: 0
Study: 34779303

Group type: EXPERIMENTAL
Intervention: Telephone genetic counseling
Number of subjects: 669

Group type: COMPARATOR
Intervention: Usual care genetic counseling
Number of subjects: 669
Study: 32735218

Group type: EXPERIMENTAL
Intervention: mHealth intervention (smartphone-assisted program using Samsung Health and WhatsApp)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Conventional behavior change intervention only
Number of subjects: 33
Study: 33415653

Group type: EXPERIMENTAL
Intervention: PIFU (ePRO-based individual follow-up)
Number of subjects: 124

Group type: COMPARATOR
Intervention: SFU (standard follow-up care)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: PIFU and SFU
Number of subjects: 124
Study: 33430797

Group type: EXPERIMENTAL
Intervention: Deep learning model for diagnosing dystrophinopathies on thigh muscle MRI images
Number of subjects: 432

Group type: COMPARATOR
Intervention: Skilled radiologists
Number of subjects: 432
Study: 32948695

Group type: EXPERIMENTAL
Intervention: Proposed digital twin test
Number of subjects: 0

Group type: COMPARATOR
Intervention: Transmission disequilibrium test
Number of subjects: 0
Study: 35145122

Group type: EXPERIMENTAL
Intervention: PCV-VG group
Number of subjects: 63

Group type: COMPARATOR
Intervention: VCV group
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 63
Study: 33091723

Group type: EXPERIMENTAL
Intervention: Visual score of 4 (acceptance threshold)
Number of subjects: 4322
Study: 34623746

Group type: EXPERIMENTAL
Intervention: Seton removal + surgical closure (closure group)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Seton removal alone (control group)
Number of subjects: 64
Study: 34470300

Group type: EXPERIMENTAL
Intervention: Self-reported occupational noise exposure
Number of subjects: 6318
Study: 32981872

Group type: EXPERIMENTAL
Intervention: Panoramic reconstruction (PR) images
Number of subjects: 10

Group type: COMPARATOR
Intervention: Multiplanar reconstruction (MPR) images
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Decision making by oral and maxillofacial surgeons (OMFSs)
Number of subjects: 10
Study: 34863618

Group type: EXPERIMENTAL
Intervention: COVID-19 vaccination intent among residents
Number of subjects: 969

Group type: EXPERIMENTAL
Intervention: COVID-19 vaccination intent among staff
Number of subjects: 969

Group type: COMPARATOR
Intervention: Factors associated with vaccine deliberation and reluctance
Number of subjects: 969

Group type: COMPARATOR
Intervention: Trend in vaccine acceptance
Number of subjects: 969
Study: 35227528

Group type: EXPERIMENTAL
Intervention: Flowable short fiber-reinforced composites (SFRC)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Packable short fiber-reinforced composites (SFRC)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Fiber-reinforced glass-ionomer cement (GIC) with adhesive treatment
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Fiber-reinforced glass-ionomer cement (GIC) without adhesive treatment
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Conventional glass-ionomer cement (GIC) with adhesive treatment
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Resin-modified glass-ionomer cement (GIC) with adhesive treatment
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Conventional glass-ionomer cement (GIC) without adhesive treatment
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Resin-modified glass-ionomer cement (GIC) without adhesive treatment
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Dual-cure composite resin
Number of subjects: 250

Group type: COMPARATOR
Intervention: Conventional composite resin (control)
Number of subjects: 250
Study: 32151432

Group type: EXPERIMENTAL
Intervention: Anemia
Number of subjects: 1748
Study: 35753316

Group type: EXPERIMENTAL
Intervention: Fractional doses of RTS,S/AS01E (Fx012-14)
Number of subjects: 1609

Group type: EXPERIMENTAL
Intervention: Standard regimen of RTS,S/AS01E (R012-14 and R012-20)
Number of subjects: 1609

Group type: COMPARATOR
Intervention: Rabies vaccine (control group)
Number of subjects: 1609

Group type: EXPERIMENTAL
Intervention: Full doses of RTS,S/AS01E (R012-20)
Number of subjects: 1609

Group type: EXPERIMENTAL
Intervention: Full doses of RTS,S/AS01E (R012-14)
Number of subjects: 1609

Group type: EXPERIMENTAL
Intervention: Fractional doses of RTS,S/AS01E (Fx017-20)
Number of subjects: 1609
Study: 33131033

Group type: EXPERIMENTAL
Intervention: O3-autohemotherapy plus BAT
Number of subjects: 60

Group type: COMPARATOR
Intervention: BAT only (Control)
Number of subjects: 60
Study: 32052032

Group type: EXPERIMENTAL
Intervention: GLP-1 (0.8 pmol/kg/min)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Vehicle (rate-matched infusion)
Number of subjects: 18
Study: 36159932

Group type: EXPERIMENTAL
Intervention: Jin's three-needle therapy (JTNT)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 114

Group type: COMPARATOR
Intervention: Waitlist control (no treatment)
Number of subjects: 114
Study: 32079855

Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Physical exercise
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Hypertension
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Family history of CHD
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: BMI
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: GG genotype at rs10757278
Number of subjects: 310
Study: 35788240

Group type: EXPERIMENTAL
Intervention: Cognitive Functional Therapy (CFT) intervention, 5 to 7 sessions based on clinical progression.
Number of subjects: 152

Group type: COMPARATOR
Intervention: Sham intervention, 6 sessions of photobiomodulation using a detuned device and neutral conversation.
Number of subjects: 152
Study: 33722669

Group type: EXPERIMENTAL
Intervention: High-carbohydrate/protein breakfast
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nutrition-manipulation inducing plasma tryptophan fluctuation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: fMRI activation in the parietal lobule during risk-processing
Number of subjects: 0